SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-129275
Filing Date
2019-04-30
Accepted
2019-04-30 16:05:57
Documents
8
Period of Report
2019-06-27
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d623378ddef14a.htm DEF 14A 317330
2 GRAPHIC g623378g11y77.jpg GRAPHIC 26592
3 GRAPHIC g623378g21j11.jpg GRAPHIC 24658
4 GRAPHIC g623378g24p24.jpg GRAPHIC 23255
5 GRAPHIC g623378g45a86.jpg GRAPHIC 37394
6 GRAPHIC g623378g48k66.jpg GRAPHIC 28639
7 GRAPHIC g623378g56z83.jpg GRAPHIC 16586
8 GRAPHIC g623378g57f70.jpg GRAPHIC 22487
  Complete submission text file 0001193125-19-129275.txt   566464
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEF 14A | Act: 34 | File No.: 001-37695 | Film No.: 19781650
SIC: 2834 Pharmaceutical Preparations